Revenue breakdown of Yiling Pharmaceutical 2022, by market
In 2022, Yiling Pharmaceutical made more than 96 percent of its revenue in the domestic market. The company became highly profitable since the start of the COVID-19 pandemic when its traditional Chinese medicine product Lianhua Qingwen gained national popularity.